264 related articles for article (PubMed ID: 28703764)
1. Erythropoietin and Its Angiogenic Activity.
Kimáková P; Solár P; Solárová Z; Komel R; Debeljak N
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703764
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in tumor angiogenesis.
Annese T; Tamma R; Ruggieri S; Ribatti D
Exp Cell Res; 2019 Jan; 374(2):266-273. PubMed ID: 30576679
[TBL] [Abstract][Full Text] [Related]
3. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic effects of erythropoietin.
Ribatti D
Int Rev Cell Mol Biol; 2012; 299():199-234. PubMed ID: 22959304
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
[TBL] [Abstract][Full Text] [Related]
6. The role of erythropoietin in regulating angiogenesis.
Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
[TBL] [Abstract][Full Text] [Related]
7. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
[TBL] [Abstract][Full Text] [Related]
10. Brain and cancer: the protective role of erythropoietin.
Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
[TBL] [Abstract][Full Text] [Related]
11. Review of the role of erythropoietin in critical leg ischemia.
Joshi D; Tsui J; Ho TK; Selvakumar S; Abraham DJ; Baker DM
Angiology; 2010 Aug; 61(6):541-50. PubMed ID: 20462898
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin, erythropoiesis and beyond.
Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and cancer: the unintended consequences of anemia correction.
Debeljak N; Solár P; Sytkowski AJ
Front Immunol; 2014; 5():563. PubMed ID: 25426117
[TBL] [Abstract][Full Text] [Related]
15. The Many Facets of Erythropoietin Physiologic and Metabolic Response.
Suresh S; Rajvanshi PK; Noguchi CT
Front Physiol; 2019; 10():1534. PubMed ID: 32038269
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
17. Epo and non-hematopoietic cells: what do we know?
Ogunshola OO; Bogdanova AY
Methods Mol Biol; 2013; 982():13-41. PubMed ID: 23456860
[TBL] [Abstract][Full Text] [Related]
18. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin in cancer: an update.
Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
[TBL] [Abstract][Full Text] [Related]
20. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
